Records containing: Hemophilia A
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-03-27Intensive Replacement Treatment in Haemophilia Patients With Synovitis
-
CLINICAL_TRIALS study record update · 2024-03-21Acquired Hemophilia A and Autoimmunity. Study of Lymphocyte Populations and Myeloid-Derived Suppressor Cells
-
CLINICAL_TRIALS study record update · 2024-03-07Phase 4, Multicenter, Prospective, Interventional, Post-Marketing Study in Hemophilia A Patients in India Receiving ADVATE as On-Demand or Prophylaxis Under Standard Clinical Practice
-
CLINICAL_TRIALS study record update · 2024-03-07A Phase III Clinical Study Evaluating the Efficacy and Safety of On-demand Treatment and Perioperative Replacement Therapy With Recombinant Human Coagulation Factor VIII for Injection in Treated Severe Hemophilia A
-
CLINICAL_TRIALS study record update · 2024-03-06A Randomized, Multicenter, Open-Label, Phase III Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus No Prophylaxis in Hemophilia A Patients
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-02-26Post Marketing Surveillance Study for ADYNOVATE in South Korea
-
CLINICAL_TRIALS study record update · 2024-02-20ET3-201: Phase 1 Study of Hematopoietic Stem Cell Transplantation (HSCT) Gene Therapy Incorporating a Lentiviral Vector (LV) Encoding a High Expressing Factor VIII Transgene for Treatment of Severe Hemophilia A
-
CLINICAL_TRIALS study record update · 2024-02-13A Phase 3 Open-label, Multicenter Study of the Safety, Efficacy, and Pharmacokinetics of Intravenous Recombinant Coagulation Factor VIII Fc-von Willebrand Factor-XTEN Fusion Protein (rFVIIIFc-VWF-XTEN; BIVV001) in Previously Treated Pediatric Patients <12 Years of Age With Severe Hemophilia A
-
CLINICAL_TRIALS study record update · 2024-01-05Emicizumab PUPs and Nuwiq ITI Study
-
CLINICAL_TRIALS study record update · 2023-12-13An Open-Label, Multicenter Evaluation of the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection (FRSW107) in Adolescent and Adult Patients With Hemophilia A.
-
CLINICAL_TRIALS study record update · 2023-12-12Health Related Quality of Life of Youth and Young Adults With Haemophilia A Treated With Efmoroctocog Alfa in Russia
-
CLINICAL_TRIALS study record update · 2023-12-06Study of Surgical Practices in Patient With Haemophilia A or B Treated With an Extended Half-life Recombinant Factor VIII-Fc or IX-Fc (ELOCTA®, ALPROLIX®)
-
CLINICAL_TRIALS study record update · 2023-11-28A Phase 3 Open-Label, Single-Arm Study To Evaluate The Efficacy and Safety of BMN 270, an Adeno-Associated Virus Vector-Mediated Gene Transfer of Human Factor VIII in Hemophilia A Patients With Residual FVIII Levels ≤ 1 IU/dL Receiving Prophylactic FVIII Infusions
-
CLINICAL_TRIALS study record update · 2023-11-28REAL: A Pre-/Post-Intervention Descriptive Analysis and Cross-Sectional Survey to Evaluate Real-World Treatment Outcomes, Consumption, and Satisfaction With Damoctocog Alfa Pegol in US Hemophilia Treatment Centers
-
CLINICAL_TRIALS study record update · 2023-10-30Health-related Quality of Life Outcomes and Bleeding Rates Among Patients With Severe Hemophilia A on Emicizumab: Real World Data
-
CLINICAL_TRIALS study record update · 2023-10-05A Multi-center, Prospective Study Evaluating the Rate of Inhibitor Recurrence Following Successful ITI in Patients Receiving Ongoing Once Per Weekly Factor VIII Therapy Along With Emicizumab and in Patients Who Discontinue FVIII Therapy and Are on Emicizumab for Prophylaxis
-
CLINICAL_TRIALS study record update · 2023-09-05Effects of Emicizumab vs. Factor VIII Prophylaxis on Joint and Bone Health in Severe Hemophilia A
-
CLINICAL_TRIALS study record update · 2023-08-29A Single-Arm, Multicenter, Open-label Phase III Expansion Trial Evaluating Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection (FRSW107) in Adolescent and Adult Patients With Hemophilia A
-
CLINICAL_TRIALS study record update · 2023-08-28Understanding the Alterations in Coagulation Factor Levels in Patients With End Stage Liver Disease
-
CLINICAL_TRIALS study record update · 2023-08-22A Phase I, Multicentre, Open-label Study to Evaluate the Safety and Pharmacokinetic of Recombinant Human Coagulation Factor VIII, Fc Fusion Protein for Injection in Children With Severe Hemophilia A
-
CLINICAL_TRIALS study record update · 2023-08-14World Bleeding Disorders Registry
-
CLINICAL_TRIALS study record update · 2023-08-08Patterns of Hemophilia Care in Patients Admitted in Assiut Children University Hospital
-
CLINICAL_TRIALS study record update · 2023-08-08Evaluation of Viscoelastic Properties of Lower Extremity Muscles in Patients With Hemophilia
-
CLINICAL_TRIALS study record update · 2023-08-01Impact of Emicizumab on ACT (Activated Clotting Time) Using the i-STAT Alinity Analyzer: In Vitro Study in Severe Hemophiliacs A and Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2023-07-24Real-World Effectiveness of PEGylated, Recombinant Antihemophilic Factor (Adynovate) Prophylaxis in Patients With Hemophilia A in Canada: A Retrospective, Intra-patient Comparison With a Before-After Design